13 consecutive years of dose sales growth. 16.8% compound annual growth in the share price over 10 years *. 0.8% growth in sales in 2017. 21.5% compound annual growth in sales over ten years *.
* as at 30 June 2017
13 consecutive years of dose sales growth. 16.8% compound annual growth in the share price over 10 years *. 0.8% growth in sales in 2017. 21.5% compound annual growth in sales over ten years *.
You are about to leave the Sirtex Web site. This link is provided to you as a service and will take you to a site maintained by a third party who is solely responsible for the content.
Please be aware that Sirtex takes no responsibility for content of these external sites, nor do we endorse, warrant or guarantee the products, services or information described or offered on other internet sites.
Click 'Continue' to proceed to the third-party Web site.
The Sirtex site you are linking to is intended only for healthcare practitioners and patients outside your current region.
Any products discussed herein may have different approved product labeling; therefore, any information provided may not be appropriate for use in your region.
Click 'Continue' to proceed to the other Sirtex region Web site.
